Positive Opinion For Halozyme And Baxter International

The European Medicines Agency granted a Positive Opinion to Halozyme Therapeutics Inc. (Nasdaq: HALO) and Baxter International Inc. (NYSE: BAX) for the use of HyQvia to treat primary and secondary immunodeficiencies. Shares of Halozyme leaped $1.63 to close at $6.90 while Baxter International stock gained 88 cents to close at $70.94.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here